 Applied DNA Sciences NASDAQ: APDN shares are trading higher after the U.S. Food and Drug Administration published communication that identifies the companys Linea COVID-19 Assay Kit as one of only two tests marketed under the FDAs Emergency Use Authorization. The tests are potentially able to identify certain SARS-CoV-2 mutations, including a mutation found in the U.K. 